Matthieu Corvaisier
Overview
Explore the profile of Matthieu Corvaisier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
361
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhou J, Corvaisier M, Malycheva D, Alvarado-Kristensson M
Cancers (Basel)
. 2022 Dec;
14(23).
PMID: 36497405
Oncogenic transformation drives adaptive changes in a growing tumor that affect the cellular organization of cancerous cells, resulting in the loss of specialized cellular functions in the polarized compartmentalization of...
2.
Corvaisier M, Zhou J, Malycheva D, Cornella N, Chioureas D, Gustafsson N, et al.
Commun Biol
. 2021 Jun;
4(1):767.
PMID: 34158617
Changes in the location of γ-tubulin ensure cell survival and preserve genome integrity. We investigated whether the nuclear accumulation of γ-tubulin facilitates the transport of proliferating cell nuclear antigen (PCNA)...
3.
Corvaisier M, Alvarado-Kristensson M
Cancers (Basel)
. 2020 Oct;
12(11).
PMID: 33114224
The nuclear architecture describes the organization of the various compartments in the nucleus of eukaryotic cells, where a plethora of processes such as nucleocytoplasmic transport, gene expression, and assembly of...
4.
El Amrani M, Corfiotti F, Corvaisier M, Vasseur R, Fulbert M, Skrzypczyk C, et al.
Mol Carcinog
. 2019 Aug;
58(11):1985-1997.
PMID: 31373074
Growing body of evidence suggests that epithelial-mesenchymal transition (EMT) is a critical process in tumor progression and chemoresistance in pancreatic cancer (PC). The aim of this study was to analyze...
5.
Rossello C, Lindstrom L, Eklund G, Corvaisier M, Kristensson M
Int J Mol Sci
. 2018 Oct;
19(10).
PMID: 30347727
In cytoplasm, protein γ-tubulin joins with various γ-tubulin complex proteins (GCPs) to form a heterotetramer γ-tubulin small complex (γ-TuSC) that can grow into a ring-shaped structure called the γ-tubulin ring...
6.
Gibault F, Coevoet M, Sturbaut M, Farce A, Renault N, Allemand F, et al.
Cancers (Basel)
. 2018 May;
10(5).
PMID: 29738494
Intrinsically disordered protein YAP (yes-associated protein) interacts with TEADs transcriptional factors family (transcriptional enhancer associated domain) creating three interfaces. Interface 3, between the Ω-loop of YAP and a shallow pocket...
7.
Gibault F, Bailly F, Corvaisier M, Coevoet M, Huet G, Melnyk P, et al.
ChemMedChem
. 2017 Mar;
12(12):954-961.
PMID: 28334506
Porphyrin derivatives, in particular verteporfin (VP), a photosensitizer initially designed for cancer therapy, have been identified as inhibitors of the YAP-TEAD interaction and transcriptional activity. Herein we report the efficient...
8.
Corvaisier M, Bauzone M, Corfiotti F, Renaud F, El Amrani M, Monte D, et al.
Oncotarget
. 2016 Aug;
7(35):56699-56712.
PMID: 27527859
Our aim was to decipher the role and clinical relevance of the YAP/TAZ transcriptional coactivators in the regulation of the proliferation/quiescence balance in human colon cancer cells (CCC) and survival...
9.
Gibault F, Corvaisier M, Bailly F, Huet G, Melnyk P, Cotelle P
Curr Med Chem
. 2016 Mar;
23(11):1171-84.
PMID: 26980565
Background: Verteporfin is a porphyrinic photosensitizer clinically used for the photodynamic treatment of age-related macular degeneration. It has been identified almost simultaneously as a YAP/TEAD and an autophagosome inhibitor. Over...
10.
Touil Y, Igoudjil W, Corvaisier M, Dessein A, Vandomme J, Monte D, et al.
Clin Cancer Res
. 2013 Dec;
20(4):837-46.
PMID: 24323901
Purpose: Metastasis and drug resistance are the major limitations in the survival and management of patients with cancer. This study aimed to identify the mechanisms underlying HT29 colon cancer cell...